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Studies on the Morphogenesis of Murine Cytomegalovirus 
F. Weiland, GM. Keil, MJ. Reddehase, U.H. Koszinowski 
Federal Research Centre for Vi rus Diseases o f A n i m a l s , T ü b i n g e n , F R G 
Key Words. Murine cytomegalovirus • Morphogenesis • Electron microscopy • 
Multicapsid virions 
Summary. Two modes of assembly of murine cytomegalovirus (MCMV) were observed in 
cultured mouse embryo fibroblasts, generating two morphologically different types of viral 
particles: monocapsid virions and multicapsid virions. The assembly of nucleocapsids 
appeared to be the same for both types of morphogenesis. Three successive stages of 
intranuclear capsid formation could be distinguished: capsids with electron-lucent cores, 
coreless capsids, and capsids with dense cores. Some of the capsids were enveloped at the 
inner nuclear membrane to form monocapsid virions, which were first detectable in the 
perinuclear cisterna. Other capsids left the nucleus via nuclear pores and usually entered 
cytoplasmic capsid aggregates that received an envelope by budding into extended cytoplas-
mic vacuoles, thereby forming multicapsid virions. Since the formation of multicapsid virions 
is not restricted to cell culture conditions and also occurs in vivo in immunosuppressed mice, 
multicapsid virions may play a role in the pathogenesis of cytomegalovirus infection. 
Cytomegaloviruses cause severe clinical 
Symptoms only in the immunologically im-
mature or immunosuppressed host [for re-
view see Hamilton, 1982], indicating that in 
the immunocompetent host the immune Sys-
tem is involved in the control of acute in-
fection and the establishment of viral la-
tency. Infection of mice with murine cyto-
Address inquiries to: D r . Frank Wei l and , Federal 
Research Centre for Virus Diseases o f A n i m a l s , P O 
Box 1149, D-7400 T ü b i n g e n ( F R G ) 
Received: June 20,1986 
Revised: September 12,1986 
megalovirus (MCMV) proved to be a con-
venient virus-host model to study aspects of 
herpesvirus latency, recurrence, and patho-
genesis [Brody and Craighead, 1974; Jordan 
et al., 1977; Mayo et al., 1977; Bräutigam et 
al., 1979; Shanley et al., 1982]. A morphologic 
feature special to M C M V is the preferential 
formation of multicapsid virions in addition 
to the regulär development of monocapsid 
virions during in vitro infection of embryonic 
fibroblasts [Hudson et al., 1976a], whereas 
the generation of twin capsid forms or oligo-
capsid virions is a rare event in cells infected 
with herpes simplex virus [Nii et al., 1968; 
Watson, 1973] and also in cells infected with 
Morphogenesis o f M u r i n e Cytomegalovirus 193 
rodent cytomegaloviruses other than M C M V 
[Fong et al., 1979; Bruggeman et al., 1982]. 
Multicapsid virions of M C M V were not ob-
served in salivary gland tissue during in-
fection of immunocompetent mice. Only re-
cently has it been observed that multicapsid 
virions are also formed in vivo in fibroblastic 
lung cells during infection of immunosup-
pressed mice [Reddehase et al., 1985]. The 
origin of the virion envelope may be decisive 
for its molecular composition and thus for 
its immunogenic properties. Therefore, we 
studied the ultrastructural morphogenesis of 
both types of M C M V virions, monocapsid as 
well as multicapsid virions. 
Materials and Methods 
Virus and Infection Conditions 
M C M V (strain Smith , A T C C VR-194) was ob-
tained from the Amer i can Type Cul ture Co l l ec t ion , 
Rockwi l l e , M d . , U S A and was propagated in 
B A L B / c mouse embryo Fibroblast cells. Tertiary fi-
broblasts were prepared from 15- to 17-day-old 
B A L B / c embryos as described [ K e i l et a l . , 1984]. Ce l l s 
were infected with M C M V by employing the tech-
nique o f centrifugal (800 g for 30 min) enhancement 
o f infectivity [Osborn and Walker , 1968; Hudson et 
al . , 1976b], which resulted in an M O I o f 20 P F U per 
cel l . T o inhibit viral D N A synthesis, cells were infec-
ted with M C M V in the presence of 250 | i g / m l phos-
phonoacetic acid or 20 mM hydroxyurea ( H U ) and 
maintained in the presence o f the inhibi tor . 
Electron Microscopy 
For electron microscopy, in situ Fixation o f cel l 
monolayers (16-28 h postinfection) was performed 
wi th 2.5% glutaraldehyde in 0.1 M sodium cacodylate 
buffer ( p H 7.2) for 2 h. After r insing with cacodylate 
buffer, the cells were gently scraped off, collected by 
centrifugation, and postfixed in 1% osmium tetroxide. 
Specimens were dehydrated in acetone and em-
bedded in Arald i te . Sections were cut wi th a Reichert 
O m U 3 ultramicrotome. Semithin sections (1 u,m) were 
stained with toluidine blue to select sites o f interest by 
l ight microscopy. Ul t ra th in sections o f selected sites 
were then stained wi th uranyl acetate and lead citrate, 
and examined i n a Siemens 101 electron microscope at 
80 k V . 
Results 
Assembly of Nucleocapsids 
The technique of centrifugal enhance-
ment of infectivity [Osborn and Walker, 
1968; Hudson et al., 1976b] was applied to 
synchronize the inoculation. Two hours after 
infection, more than 90% of the mouse em-
bryo fibroblasts in a semiconfluent mono-
layer expressed the first gene product of 
M C M V , the immediate-early phosphopro-
tein IE pp89 [Keil et al., 1985] in the nucleus, 
as detected by indirect immunofluorescence 
(not shown). This finding proved that viral 
replication started with a high degree of syn-
chronicity. Viral D N A synthesis defining the 
beginning of the late phase of viral replica-
tion occurs at about 16 h postinfection [Ebel-
ing et al., 1983], and at that time ultrastructur-
al alterations could be detected by electron 
microscopy. 
Fibroblasts displayed enlarged nuclei 
with a pale nucleoplasm and delicately mar-
ginated chromatin. Faint amorphous mate-
rial was arranged in two or three focal areas 
in the nuclear matrix between the nucleoli. 
Coinciding with increasing staining affinity, 
the amorphous material acquired a more reti-
cular appearance, and the first forms of viral 
capsids, typified by an electron-lucent core, 
emerged in the nucleus. Thereupon the focal 
areas fused to form a Single large inclusion 
body composed of diffusely or reticularly 
arranged amorphous material. This inclu-
sion occupied the whole center of the nucleus 
and was surrounded by a clear zone of nucle-
oplasm that separated the inclusion from the 
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Fig. 1. Capsids in the nucleus o f 
an M C M V - i n f e c t e d ce l l , a Caps ids 
with electron-lucent core. bl,2 In-
completely formed capsids o f the 
type as shown in a. c l Coreless cap-
sids; arrow: nucleocapsid. c2 
Empty capsid possessing a distinct 
orifice. Bar marker represents 200 
nm. 
Fig. 2. Different stages in intra-
nuclear incorporat ion o f spider-
l ike filaments (deoxyribonucleop-
rotein Strands) into coreless capsids 
finally forming the mature nucleoc-
apsid. a Coreless capsid wi th an 
orifice. b Spider-l ike filamentous 
structure located in the nuclear ma-
trix. c Contact between an osmio-
ph i l i c 'spider ' and an empty capsid . 
d-i Different forms o f association 
o f 'spiders ' with empty capsids. k 
Mature nucleocapsid. Bar marker 
represents 200 nm. 
nuclear membrane. This zone was identical 
to a halo observed by light microscopy. Fre-
quently, Single capsids or Clusters of capsids 
were interspersed among the amorphous ma-
terial of the inclusion body. Only in single 
cases were the majority of capsids located in 
the nucleoplasm of the halo region (data not 
shown). 
At that stage three types of capsids were 
observed simultaneously in the nucleus of 
individual MCMV-infected cells: (i) Capsids 
with a diameter of 100 nm containing an 
electron-lucent core of hexagonal symmetry 
(flg. la). Incompletely formed crescent 
shaped capsids with crescent shaped cores 
were encountered occasionally (fig. lbl,2). 
These putatively represented capsids in a 
stage of assembly. (ii) Capsids with a hex-
agonal profile devoid of a core (fig. lcl). 
These capsids differed in size but usually 
were slightly larger than those described 
above. (iii) Capsids containing an electron-
dense fuzzy or more Condensed core that was 
located in the center (fig. lcl , arrow; fig. 2k). 
Their diameters were 100 nm. These capsids 
were designated nucleocapsids and were 
considered to represent mature capsids con-
taining viral D N A . 
As already mentioned above, the first cap-
sids emerging in the nucleus were those with 
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F i g . 3. Nucleocapsids leaving 
the nucleus. a B ü d d i n g o f a nucle-
ocapsid into the perinuclear Space, 
b Enve loped monocaps id v i r ion 
freely ly ing i n the perinuclear cist-
erna. c, d Nucleocaps ids located i n 
the cytoplasm close to nuclear 
pores. Ba r marker represents 200 
nm. 
electron-lucent cores. The formation of nu-
cleocapsids was selectively halted at this 
stage when cells were infected in presence 
of H U , whereas any capsid assembly was 
prevented when viral D N A synthesis was 
blocked with phosphonoacetic acid. Core-
less capsids were formed only in the absence 
of H U when transition to the late (y) phase 
of viral gene expression was not inhibited. 
These findings strongly suggest that coreless 
capsids represent a more advanced stage in 
the assembly of nucleocapsids, but since in-
termediate stages were not observed it could 
not be established whether capsids with elec-
tron-lucent cores represented direct prede-
cessors of coreless capsids or whether they 
were an independent structure of as yet un-
known function. 
Coreless capsids possessed a distinct ori-
fice (fig. Ic2,2a). Electron-dense filamentous 
material with a spider-like appearance (most 
likely representing deoxyribonucleoprotein 
Strands) originated separately in the nuclear 
matrix (fig. 2b). These osmiophilic 'spiders' 
occasionally had fibers protruding towards 
the empty capsids (fig. 2c). Often they were 
detected in different stages of association 
with coreless capsids (fig. 2d—i). Capsids with 
electron-lucent cores devoid of D N A also 
accumulated in the presence of H U in cells 
infected with herpes simplex virus and, after 
removal of the inhibitor, EDTA-sensitive nu-
cleoprotein filaments have been observed in 
structural association with capsids, which 
appear to be stages in a process of entering 
[Friedmann et al., 1975]. It is plausible that 
the spider-like filaments of M C M V enter ra-
ther than leave the coreless capsids, finally 
forming the electron-dense compact deoxy-
ribonucleoprotein core that is characteristic 
of the mature nucleocapsid (fig. 2k). In con-
clusion, apart from minor differences in ul-
trastructural details, the assembly of M C M V 
nucleocapsids follows the scheme common 
to herpesviruses. 
Formation of Monocapsid and Multicapsid 
Virions 
Nucleocapsids were detected in intimate 
contact with the inner nuclear membrane 
(some of them during the process of budding) 
and were partly enveloped by a thickened 
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area of the inner nuclear membrane (fig. 3a). 
The budding process resulted in the release 
of enveloped monocapsid virions into the 
perinuclear cisterna (fig. 3b). 
In the cytoplasm, nonenveloped single 
nucleocapsids were not randomly distri-
buted, but appeared in conspicuous proxi-
mity to nuclear pores (fig. 3c, d), strongly 
suggesting that these nucleocapsids had just 
left the nucleus via that passageway. Passing 
through may be a rapid process, which would 
explain why nucleocapsids were not ob-
served in the pore. The antithesis predicts 
de-envelopment of monocapsid virions 
[Severi et al., 1979] followed by penetration 
into the nucleus via the nuclear pores. Such a 
view, however, is neither plausible nor has 
any precedent in published reports on her-
pesvirus morphogenesis. 
Nucleocapsids aggregated in the cyto-
plasm and were embedded in electron-dense 
deposits, consisting of an amorphous, fine 
granulär substance (fig. 4). At lower magnifi-
cation such Clusters appeared as compact 
cytoplasmic inclusions. Frequently, the nu-
cleocapsids were arranged predominantly at 
the margin of the inclusion. Only rarely were 
the amorphous matrix material and nucleo-
capsids seen separately in the cytoplasm. Be-
sides mature nucleocapsids, coreless capsids 
also entered the Clusters, whereas capsids 
containing the electron-lucent altered form 
of the core described above (fig. la) were 
never encountered outside the nucleus. 
In the Golgi region, Clusters consisting of 
variable numbers of embedded capsids (oc-
casionally only one) were enveloped by bud-
ding into cytoplasmic vacuoles (fig. 5a, b), 
thereby forming either multicapsid virions or 
monocapsid virions that contained a signifi-
cant amount of matrix material as tegument, 
in contrast to those monocapsid virions that 
were enveloped at the inner nuclear mem-
brane. Multicapsid virions as well as mono-
capsid virions formed by either mechanism 
were enclosed in smooth cytoplasmic vacu-
oles (fig. 5c, d) and released into the extracel-
lular space (fig. 5e). Studies on virion mor-
phogenesis in various tissues of virus-infec-
ted immunosuppressed mice have shown 
that in the absence of immune control, 
M C M V replicates in vivo exactly as demon-
strated for cultured fibroblasts. The presence 
of monocapsid virions in the perinuclear cist-
erna and the release of multicapsid virions 
have been shown for infected fibroblastic 
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Fig. 5. Envelopment o f cyto-
plasmic nucleocapsids. Simultane-
ous budd ing o f nucleocapsids into 
cytoplasmic vacuoles thereby form-
ing mul t icaps id virions containing 
various numbers o f nucleocapsids 
a,b. M u l t i c a p s i d c and monocaps id 
d v i r ions enclosed in cytoplasmic 
vacuoles and released into the ex-
tracellular space e. Bar marker rep-
resents 200 nm. 
cells of the alveolar septa during interstitial 
M C M V pneumonia [Reddehase et al., 1985]. 
From our findings, we envision the course 
of M C M V morphogenesis as schematically 
outlined in fig. 6. 
Discussion 
M C M V differs from other members of the 
herpesvirus family by producing two differ-
ent types of viral particles simultaneously in 
the same individual cell: monocapsid virions 
and multicapsid virions. This uncommon 
feature may account for properties important 
for the induction of an immune response and 
for the course of pathogenesis. To clarify the 
origin of the virion envelopes we studied the 
ultrastructural morphogenesis of M C M V . 
It was found that both types of virion have 
the first steps of morphogenesis in common -
the assembly of nucleocapsids in the nuclei 
of infected cells. In accordance with findings 
of Lussier et al. [1974] and Kurimura et al. 
[1977], three types of capsids were observed: 
capsids with electron-lucent cores, coreless 
capsids, and capsids with dense cores. Con-
sistent with the assembly of herpes simplex 
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Fig. 6. a Part o f an M C M V - i n f e c t e d cel l . (1) Intranuclear capsids in different stages o f assembly. (2) 
Accumula t ion o f cytoplasmic capsids. (3) B ü d d i n g of cytoplasmic capsids. (4) Intravacuolar mul t icaps id 
v i r ion . (5) Extracel lular monocapsid v i r ion . (6) Extracellular mul t icaps id v i r ion . Bar marker represents 1 Jim. b 
Schematic representation o f the supposed course o f M C M V morphogenesis. 
virus capsids [Schwartz and Roizman, 1969], 
capsids with electron-lucent cores were never 
seen as free particles or enveloped virion-like 
particles outside the nucleus, whereas for the 
infection of human fibroblasts with strains of 
human cytomegalovirus (HCMV), Irmiere 
and Gibson [1983] have reported noninfec-
tious enveloped particles (NIEPs) which are 
characterized by capsids containing a core 
similar in structure to that of intranuclear 
H C M V B-capsids, which correspond to the 
M C M V capsids with electron-lucent cores. 
In a more recent report the same authors 
provide evidence that NIEPs are in fact enve-
loped B-capsids and suggest that an assem-
bly protein forming the core before D N A 
packaging is modified or removed in con-
junction with D N A packaging [Irmiere and 
Gibson, 1985]. Our studies with H U and re-
sults obtained for herpes simplex virus by Nii 
et al. [1968] and Friedmann et al. [1975] allow 
the analogous conclusion, namely that cap-
sids with electron-lucent cores do not contain 
the viral genome and represent a premature 
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stage in nucleocapsid assembly. Likewise it is 
now established for cytomegaloviruses [Ka-
nich and Craighead, 1972; Haguenau and 
Michelson-Fiske, 1975; Kurimura et al., 1977] 
and for herpes simplex virus [Friedmann et 
al., 1975; Luetzeler and Heine, 1978] that viral 
deoxyribonucleoprotein Strands enter the 
coreless capsids to form mature nucleocap-
sids. 
Büdding at the inner nuclear membrane is 
the most frequent way of monocapsid virion 
formation for most herpesviruses [Shipkey et 
al., 1967; Darlington and Moss, 1968]. Cy-
tomegaloviruses represent an exception to 
the rule since virions receive the envelope 
predominantly by budding into cytoplasmic 
vesicles [Todd and Storz, 1983]. Another 
characteristic of cytomegalovirus infections 
is the formation of cytoplasmic inclusions 
consisting of embedded nucleocapsids [Luse 
and Smith, 1958; Ruebner et al., 1966; Bere-
zesky et al., 1971; Craighead et al., 1972; Hud-
son et al., 1976a; Fong et al., 1979; Storz et al., 
1984]. Release of enveloped nucleocapsid 
aggregates containing 1 to more than 20 nu-
cleocapsids, i.e. multicapsid virions, into the 
extracellular Space is, however, a prominent 
feature only during M C M V infection [Hud-
son et al., 1976a]. The occasional detection of 
bicapsid virions in other rodent cytomegalo-
virus infections [Fong et al., 1979; Brugge-
man et al., 1982] can be explained by inciden-
tal budding of two nucleocapsids into the 
same vesicle. 
The site of envelopment of M C M V nucle-
ocapsid aggregates remained to be eluci-
dated. Because it was considered unlikely 
that extended aggregates bud at the nuclear 
membrane or into cytoplasmic vesicles in the 
way single nucleocapsids do [Leestma et al., 
1969], budding at the cell membrane ap-
peared to be a plausible alternative. None-
theless, our studies have now established that 
the aggregates do not bud at the cell mem-
brane, but bud exclusively into extended 
cytoplasmic vacuoles derived from the Golgi 
apparatus. On the other hand, monocapsid 
virions developed only incidentally by this 
mode from nucleocapsids that did not join 
aggregates. M C M V monocapsid virions 
were primarily generated by budding at the 
inner nuclear membrane. Al l three types of 
M C M V virions were transported through the 
cytoplasm enclosed by cytoplasmic unit 
membranes and were released into the ex-
tracellular space by exocytosis. In conclu-
sion, neither multicapsid virions nor the two 
types of monocapsid virions received the en-
velope by budding at the cell membrane, and 
the origin of the multicapsid virion envelope 
differed from that of most monocapsid vir-
ions. 
These results could have an influence on 
the interpretation of recent findings. First, 
production of multicapsid virions in fibro-
blast cells in culture and of monocapsid vir-
ions in vivo in cells of the salivary glands has 
been related to attenuation and virulence, 
respectively [Osborn and Walker, 1970; 
Chong and Mims, 1981; Jordan and Takagi, 
1983]. Since monocapsid virions and multi-
capsid virions gain their envelope at different 
sites it is possible that they differ in the com-
position of their envelopes and hence also in 
their properties. Second, none of the three 
types of virions is enveloped at the cell mem-
brane. It is therefore conceivable that anti-
gens which are derived from the virion enve-
lope after integration into the cell membrane 
from without during penetration of the virion 
are not necessarily presented at the cell mem-
brane in an antigenic form during intracellu-
lar virion assembly. This might explain why a 
cytolytic T-lymphocyte clone specific for vi-
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rion structural antigen, clone Sl [Reddehase 
et al., 1986a], did not detect this antigen in the 
late phase of infection at a time when high 
amounts of virus were produced and released 
[Reddehase et al., 1986b]. 
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